Clinical Trial NCT05539248

Trial

CARE Pharma CAN106-PNH-102/201 (NCT05539248)

Clinical trial ID

NCT05539248

Drug name

CAN106

Company:

CARE Pharma Shanghai Ltd.

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

1,2

Current status

Recruiting

Start

03/2022

Substance

Research question

To evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of CAN106

Delivery method of drug

Frequency

Clinical trial locations

China